← back to search

Romas Geleziunas

Gilead Sciences (United States) · US
Area of research
Virology · Infectious Diseases
Research interest
Research focused on Immunology and Simian immunodeficiency virus, with related work in Viremia, CD8, Virology. Notable publications include 'Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys', 'B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers', and 'Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing'.
h-index
citations
2,312
works
14
NIH funding
primary concept
email

Recent publications

Origin and Correlates of Viral Rebound in SIV-Infected Rhesus Macaques Following ART Discontinuation
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 2position: middledoi
Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption
The Journal of Infectious Diseases 2024cited by 3position: middledoi
Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants
Cell Host & Microbe 2023cited by 28position: middledoi
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
Science Translational Medicine 2021cited by 78position: middledoi
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals
AIDS 2021cited by 19position: middledoi
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1
Clinical Infectious Diseases 2020cited by 74position: middledoi
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
The Journal of Experimental Medicine 2020cited by 49position: middledoi
Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation
PLoS Pathogens 2020cited by 31position: middledoi
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
The Lancet HIV 2019cited by 204position: middledoi
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
Nature 2016cited by 271position: middledoi
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
PLoS Pathogens 2016cited by 165position: middledoi
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
Nature Medicine 2015cited by 480position: middledoi
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
Nature 2014cited by 628position: middledoi
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing
PLoS Pathogens 2014cited by 280position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Devi SenGupta · Gilead Sciences (United States)3 papers (2020–2024)John W. Mellors · University of Pittsburgh3 papers (2014–2021)Dan H. Barouch · Harvard University3 papers (2020–2025)Louis J. Picker · Oregon National Primate Research Center2 papers (2015–2025)Liao Zhang · Gilead Sciences (United States)2 papers (2020–2021)Edwin DeJesus · Orlando Immunology Center2 papers (2020–2021)Diana M. Brainard · Gilead Sciences (France)2 papers (2020–2021)Susan Guo · Gilead Sciences (United States)2 papers (2020–2021)Rebecca Begley · Gilead Sciences (United States)2 papers (2020–2021)Susan J. Little · University of California San Diego2 papers (2021–2024)Rita Humeniuk · Center for Cancer Research2 papers (2020–2021)Terri Wrin · LabCorp (United States)2 papers (2020–2021)Joseph Hesselgesser · Gilead Sciences (United States)2 papers (2014–2015)Brian Moldt · Gilead Sciences (United States)2 papers (2021–2021)Jeffrey D. Lifson · Center for Cancer Research2 papers (2015–2025)Cynthia Brinson · Brown University2 papers (2020–2021)Jeffrey J. Wallin · Gilead Sciences (United States)2 papers (2020–2021)Elena Vendrame · Gilead Sciences (United States)2 papers (2021–2024)Steven G. Deeks · University of California, San Francisco2 papers (2021–2024)Moti Ramgopal · Indiana University – Purdue University Indianapolis2 papers (2020–2021)